Modes of Degradation and Impurity Characterization in rhPTH (1–34) during Stability Studies

Ruchi Kothari; Vinod Kumar; Rajender Jena; Rashbehari Tunga; Binita Shrivastava Tunga

doi:10.5731/pdajpst.2011.00745

Research ArticleResearch

Modes of Degradation and Impurity Characterization in rhPTH (1–34) during Stability Studies

Ruchi Kothari, Vinod Kumar, Rajender Jena, Rashbehari Tunga and Binita Shrivastava Tunga

PDA Journal of Pharmaceutical Science and Technology July 2011, 65 (4) 348-362; DOI: https://doi.org/10.5731/pdajpst.2011.00745

Ruchi Kothari

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Vinod Kumar

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rajender Jena

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rashbehari Tunga

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Binita Shrivastava Tunga

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: binita.tunga72@hotmail.com

Article
Figures & Data
References
Info & Metrics
PDF

Article Information

vol. 65 no. 4 348-362

DOI

https://doi.org/10.5731/pdajpst.2011.00745

PubMed

22293522

Published By

Parenteral Drug Association (PDA)

Print ISSN

1079-7440

Online ISSN

1948-2124

History

Published online July 29, 2011.

Author Information

Ruchi Kothari,
Vinod Kumar,
Rajender Jena,
Rashbehari Tunga and
Binita Shrivastava Tunga*

Intas Biopharmaceuticals Ltd.

↵* Corresponding author: 423/P/A/GIDC, Sarkhej Bavla Highway, Moraiya-382210, Ahmedabad, India; Telephone 91-2717-660312; e-mail: binita.tunga72{at}hotmail.com

View Full Text

Cited By...

13 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Delivery of small molecules for bone regenerative engineering: preclinical studies and potential clinical applications

Cato T. Laurencin, Keshia M. Ashe, Nicole Henry, Ho Man Kan, Kevin W.-H. Lo

Drug Discovery Today 2014 19 6
Related impurities in peptide medicines

Matthias D’Hondt, Nathalie Bracke, Lien Taevernier, Bert Gevaert, Frederick Verbeke, Evelien Wynendaele, Bart De Spiegeleer

Journal of Pharmaceutical and Biomedical Analysis 2014 101
Forced degradation studies of biopharmaceuticals: Selection of stress conditions

Elnaz Tamizi, Abolghasem Jouyban

European Journal of Pharmaceutics and Biopharmaceutics 2016 98
Scaffolds as Structural Tools for Bone-Targeted Drug Delivery

Riccardo Ferracini, Isabel Martínez Herreros, Antonio Russo, Tommaso Casalini, Filippo Rossi, Giuseppe Perale

Pharmaceutics 2018 10 3
Development of controlled drug delivery systems for bone fracture-targeted therapeutic delivery: A review

Yuchen Wang, Maureen R. Newman, Danielle S.W. Benoit

European Journal of Pharmaceutics and Biopharmaceutics 2018 127
Nanocomposites drug delivery systems for the healing of bone fractures

Jianxian Chen, Akram Ashames, Manal Ali Buabeid, Khairi Mustafa Fahelelbom, Muhammad Ijaz, Ghulam Murtaza

International Journal of Pharmaceutics 2020 585
Encapsulation of Anabolic Peptide in Lipid Nano Vesicles for Osteoporosis

Sagar Salave, Dhwani Rana, Derajram Benival

Current Protein & Peptide Science 2022 23 7
Comparative Physicochemical and Biological Characterisation of the Similar Biological Medicinal Product Teriparatide and Its Reference Medicinal Product

Piroska Kovács, Tamás Schäfer, Viktor Háda, Helga Hevér, Sonja Klingelhöfer, Merle Nebel, Tanja Stadie, Róbert Kiss, Zoltán Urbányi

BioDrugs 2020 34 1
Local delivery systems of morphogens/biomolecules in orthopedic surgical challenges

Subhasis Roy, Prasenjit Mukherjee, Pradip Kumar Das, Prabal Ranjan Ghosh, Pradyot Datta, Biswanath Kundu, Samit Kumar Nandi

Materials Today Communications 2021 27
Scaffolds as Carriers of Drugs and Biological Molecules for Bone-Tissue Bioengineering

I. A. Khlusov, E. D. Porokhova, E. G. Komarova, E. A. Kazantseva, Yu. P. Sharkeev, K. A. Yurova, L. S. Litvinova

Cell and Tissue Biology 2022 16 5
Efficacy of Recombinant Human Parathyroid Hormone 1–34 and Vitamin K2 Combination Therapy in Postmenopausal Osteoporosis

Zhuo Zhang, Kun Xia, Wentao Gong, Ruopeng Mai, Peng Liu, Zhaogang Lu

Hormone and Metabolic Research 2025 57 01
Sources of Contamination in Medicinal Products and Medical Devices

2012
Validation of a liquid chromatography-high-resolution mass spectrometry method to quantify peptide-related impurities in teriparatide

Daniel A. Weisz, Sarah M. Rogstad, Kui Zeng, Eric Pang, Ilan Geerlof-Vidavsky

Journal of Pharmaceutical and Biomedical Analysis 2025 255

PreviousNext

In This Issue

PDA Journal of Pharmaceutical Science and Technology

Vol. 65, Issue 4

July/August 2011

Table of Contents
Index by Author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Modes of Degradation and Impurity Characterization in rhPTH (1–34) during Stability Studies

Message Subject (Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology

Message Body (Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 5 + 0 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Modes of Degradation and Impurity Characterization in rhPTH (1–34) during Stability Studies

Ruchi Kothari, Vinod Kumar, Rajender Jena, Rashbehari Tunga, Binita Shrivastava Tunga

PDA Journal of Pharmaceutical Science and Technology Jul 2011, 65 (4) 348-362; DOI: 10.5731/pdajpst.2011.00745

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Modes of Degradation and Impurity Characterization in rhPTH (1–34) during Stability Studies

Ruchi Kothari, Vinod Kumar, Rajender Jena, Rashbehari Tunga, Binita Shrivastava Tunga

PDA Journal of Pharmaceutical Science and Technology Jul 2011, 65 (4) 348-362; DOI: 10.5731/pdajpst.2011.00745

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
References
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Main menu

User menu

Search

Modes of Degradation and Impurity Characterization in rhPTH (1–34) during Stability Studies

Article Information

Author Information

Cited By...

In This Issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.